Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Liz Wallin, a DPhil student in the Transplantation Research Immunology Group (TRIG), is leading an exciting new three-year study on transplant failure. The study centres around 60 kidney transplant patients from Central and South West England and could be the first step towards extending the lifespan of kidney transplants.

By analysing blood and tissue samples in the lab and comparing them with clinical data such as new kidney function and possible episodes of infection and rejection, Liz hopes her work will enable her and others to understand better the processes that may cause transplant rejection. Eventually, her work could also lead to new ways to predict who may be at risk of transplant failure.

'One of the best ways of treating end-stage kidney disease is to perform a kidney transplant,' explains Liz, who is carrying out her research under the supervision of Professor Kathryn Wood. 'However, kidney transplants do not last forever, and one of the biggest problems we face is rejection. This is where the body's immune system recognises the transplant as being different to itself, and attacks it as if it were a virus or bacterium. This can occur early after the transplant and is usually easily treatable, but we are recognising that when it occurs later on it can shorten the lifespan of the transplant.'

Liz is supported by Kidney Research UK (KRUK). Her research project and its implications is featured in the summer 2015 issue of the KRUK magazine on page 5. You can also read the full article on the KRUK website.

To find out more about the Transplantation Research Immunology Group visit the TRIG webpages.

Similar stories

Discovered gene patterns can predict prostate cancer treatment response

Nearly 40,000 men are diagnosed with prostate cancer each year in the UK. Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different patient groups.

New Associate Professors announced

The University of Oxford has announced the promotion to Associate Professor of two senior academics at the Nuffield Department of Surgical Sciences.

Regent Lee wins top UKRI Future Leaders Fellowship

Dr Regent Lee of the Nuffield Department of Surgical Sciences is one of eight Oxford University academics who have been awarded significant financial funding from the UK Research and Innovation’s (UKRI) Future Leaders Fellowships Scheme.

Largest trial of carotid artery surgery and stenting finds similar long-term effects on stroke risk

Results from a major clinical trial demonstrate that both stenting and surgery are low-risk and similarly effective procedures for treating carotid artery disease.

New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection

Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.

Blog posts

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.